Invesco
SBIO.L
IE00BQ70R696
Invesco NASDAQ Biotech UCITS ETF Acc
Loading chart...

About this ETF

The Invesco Nasdaq Biotech UCITS ETF seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.

TER
0.4%

Total Expense Ratio per year

Fund Size
€432.81M

Assets under management

Holdings
246

Underlying equities

Dividend Yield
0%

Accumulating

Fundamentals & Estimates

Weighted valuation multiples and analyst forecasts

Valuation Multiples
Weighted P/E
18.06
Weighted Fwd P/E
59.17
💰 Revenue Estimates
Current Year CY
+34.79% ⌀ 18 Analysts Coverage
Next Year NY
+396.2% ⌀ 18 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
-305.44% ⌀ 16 Analysts Coverage
Next Year NY
+234.43% ⌀ 15 Analysts Coverage

Related ETFs

iShares
BTEC.L • iShares
iShares Nasdaq US Biotechnology UCITS ETF
10.11 USD
TER 0.35% 1Y +30.5%
iShares
BTEE.L • iShares
iShares Nasdaq US Biotechnology UCITS ETF
10.02 USD
TER 0.35% 1Y +30.5%
iShares
IUHE.AS • iShares
iShares S&P 500 Health Care Sector UCITS ETF
7.67 EUR
TER 0.18% 1Y +12.8%
iShares
IUHC.L • iShares
iShares S&P 500 Health Care Sector UCITS ETF
13.74 USD
TER 0.15% 1Y +16.2%
Xtrackers
XUHC.L • Xtrackers
Xtrackers MSCI USA Health Care UCITS ETF 1D
67.95 USD
TER 0.12% 1Y +12.6%
State Street
SXLV.L • State Street
State Street® SPDR® S&P® U.S. Health Care Select Sector UCITS ETF (Acc)
53.03 USD
TER 0.15% 1Y +16.1%
Invesco
XLVS.L • Invesco
Invesco Health Care S&P US Select Sector UCITS ETF Acc
846.1 USD
TER 0.14% 1Y +16.2%
iShares
UMDV.AS • iShares
iShares US Medical Devices UCITS ETF
5.5 USD
TER 0.25% 1Y -17.5%
ETF Profile
Provider
Invesco
Invesco
Fund Type
ETF
Inception Date
11/06/2014 (11 yrs)
Region
-
Strategy
-
Theme
Biotech
Distribution Policy
Accumulating
Sustainable
No

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
15/100 Low (Concentration Risk)
Diversification Score
15/100 Low (Concentration Risk)
5Y Volatility
21.2% p.a.
Max Drawdown (5Y)
-34.6%
Sharpe Ratio (5Y)
0.21
Beta Factor
0.81
Notes & Warnings
Fund Volume (AUM) Solid fund volume
🟡 Moderate analyst coverage (16.2 analysts)
🔴 Severe sector concentration risk: 100% in "Healthcare".
🔴 Extreme industry concentration: 68% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).
ende